BackKubota Pharmaceutical Holdings , Ltd. Overview

Kubota Pharmaceutical Holdings , Ltd. Receivables

Track Kubota Pharmaceutical Holdings , Ltd.'s receivables ($120K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$119000.00
↓ 88.05% YoYΔ $-877000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Kubota Pharmaceutical Holdings , Ltd. Receivables History

Loading

Kubota Pharmaceutical Holdings , Ltd. vs. peers: Receivables Comparison

Loading

Kubota Pharmaceutical Holdings , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kubota Pharmaceutical Holdings , Ltd. (KBBTF) FAQ

As of the most recent data (June 2026), KBBTF shows a receivables of $120K. That compares with $1M in the prior-year period — down 88.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KBBTF's receivables is now $120K (was $1M) — a 88.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Kubota Pharmaceutical Holdings , Ltd. is outperforming or lagging.

Tracking KBBTF's receivables over time shows whether Kubota Pharmaceutical Holdings , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $120K That compares with $1M in the prior-year period — down 88.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Kubota Pharmaceutical Holdings , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $120K) with ownership activity and broader fundamentals.

Kubota Pharmaceutical Holdings , Ltd.'s receivables is $120K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.